173154-01-3

Basic information

• Product Name: (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone
• Synonyms: (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone;2-Oxazolidinone, 3-[4-azido-2-(1-Methylethyl)-1-oxo-4-[tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-, [2S-[2[1(R*),2R*,4R*],4]]-;3-[4-azido-2-(1-Methylethyl)-1-oxo-4-[tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-, [2S-[2[1(R*),2R*,4R*],4]]-2-oxazolidinone;(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5-oxo-tetrahydrofuran-2-yl]butanoyl]-4-benzyl-oxazolidin-2-one;(4S)-3-[(2S,4S)-4-azido-4-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-2-propan-2-ylbutanoyl]-4-benzyl-1,3-oxazolidin-2-one
• CAS NO: 173154-01-3
• Molecular Formula: C₂₄H₃₂N₄O₅
• Molecular Weight: 457
• EINECS: 1312995-182-4
• Mol File: 173154-01-3.mol

Chemical Properties

• Melting Point: 105℃
• Appearance: /
• CAS DataBase Reference: (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone(CAS DataBase Reference)
• NIST Chemistry Reference: (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone(173154-01-3)
• EPA Substance Registry System: (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone(173154-01-3)

Safety Data

• Hazardous Substances Data: 173154-01-3(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
(4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone is used as a key intermediate in the synthesis of complex organic molecules, particularly in the pharmaceutical industry. Its unique structure and functional groups allow for targeted reactions and the creation of novel compounds with potential therapeutic applications.
Used in Pharmaceutical Development:
In the pharmaceutical industry, (4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone is used as a starting material for the development of new drugs. Its structural complexity and the presence of various functional groups make it a promising candidate for the creation of innovative therapeutic agents, potentially targeting a wide range of diseases and conditions.
Used in Research and Development:
(4S)-3-[(2S,4S)-4-Azido-2-(1-Methylethyl)-1-oxo-4-[(2S,4S)-tetrahydro-4-(1-Methylethyl)-5-oxo-2-furanyl]butyl]-4-(phenylMethyl)-2-Oxazolidinone is utilized in research settings to study its chemical properties, reactivity, and potential interactions with other molecules. This information can be crucial for understanding its behavior in various chemical and biological systems, as well as for identifying new applications and uses in different fields.

InChI:InChI=1/C24H32N4O5/c1-14(2)18(11-20(26-27-25)21-12-19(15(3)4)23(30)33-21)22(29)28-17(13-32-24(28)31)10-16-8-6-5-7-9-16/h5-9,14-15,17-21H,10-13H2,1-4H3/t17-,18-,19-,20-,21-/m0/s1

Upstream product

• 173154-00-2 (S)-4-benzyl-3-((2S,4R)-4-bromo-2-isopropyl-4-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-butanoyl)oxazolidin-2-one 
• 7732-18-5 water 
• 993-22-6 tetrabutylammoniun azide 
• 90719-32-7 (S)-4-Benzyl-2-oxazolidinone 
• 108-12-3 isopentanoyl chloride 
• 145589-03-3 (S)-4-benzyl-3-(3-methylbutanoyl)oxazolidin-2-one 

Downstream Products

• 934841-30-2 (3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxo-tetrahydro-furan-2-yl)pyrrolidin-2-one 
• 90719-32-7 (S)-4-Benzyl-2-oxazolidinone 
• 173154-03-5 (3S,5S)-5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]-3-isopropyldihydrofuran-2(3H)-one 
• 173154-02-4 (2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl]butanal 
• 1257529-92-2 (3S,5S)-5-((1S,3S)-1-Azido-3-(hydroxy(4-methoxy-3-(3-methoxypropoxy)phenyl)methyl)-4-methylpentyl)-3-isopropyldihydrofuran-2(3H)-one 

Relevant articles and documents

1,8-dioxo -4,5-epoxy composition and method of making the same

The invention relates to 1,8-dicarbonyl-4,5-epoxy compound and a preparation method thereof. The structure formula of the 1,8-dicarbonyl-4,5-epoxy compound is shown in the formula I, and the compound I is further opened and closed by azide substitution. A critical midbody azide lactone compound of aliskiren can be obtained at high selectivity and high yield.

A Facile, Six-Step Process for the Synthesis of (3 S,5 S)-3-Isopropyl-5-((2 S,4 S)-4-isopropyl-5-oxo-tetrahydrofuran-2-yl)-2-oxopyrrolidine-1-carboxylic Acid tert -Butyl Ester, the Key Synthetic Intermediate of Aliskiren

A facile, six-step process for the synthesis of (3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro- furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester from (S)-4-benzyloxazolidin-2-one 2 in an overall 50% yield is reported. The key transformations include: a highly efficient diastereoselective epoxidation, Lewis acid-catalyzed ring-opening with bromide, an SN2 reaction using NaN3, and a tandem reduction-cyclization reaction.

METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES

Disclosed are methods for treating Alzheimer’s disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula 1 (1) wherein the variables R1-R8 and X are defined herein.